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ABSTRACT 
INTRODUCTION: 
Since cervical cancer is highly attributed to the effects of HPV, an infectious 
agent, it  can either be prevented or treated at a pre-invasive stage there by reducing 
morbidity and mortality ; hence the need for additional biomarkers and parameters of 
cell proliferation and cell death as important diagnostic and prognostic tools. This 
study was done to evaluate the proliferative indices in cervical pre cancerous and 
cancerous lesions i.e, mitotic count in hematoxylin and eosin sained sections and  
Ki-67 and p16 in IHC stained sections. 
MATERIALS AND METHODS: 
         A total of 50 cases including CIN-1,CIN-2,CIN-3 and malignancy of the cervix 
were evaluated for mitotic figure count using light microscopy on H&E stained 
sections. Sections devoid of artefact were selected to count 1000 cells for mitotic 
figures and it was expressed in percentage. Strong nuclear positivity for Ki-67 was 
considered positive. The scoring was graded 1, 2, 3 for 10-30%,30-50% and > 50%. 
Staining intensity for p16 (nuclear or/and cytoplasmic staining) was done calculating 
the number of positive cells. The results were categorised as Grade 1,2,3 for  
1-10%,10-50% and >50%positive cells. 
CONCLUSION: 
          Ki-67 and p16 expression were seen in CIN-I,II,III and squamous cell 
carcinomas of the cervix.Ki-67 expression was in increasing grades from CIN to 
carcinoma. p16 had a better expression in high grade intra epithelial lesions (60-80%) 
and malignancies (100%)of the cervix compared to low grade dysplasias (21%). The 
mean mitotic count also showed an increase with increasing dysplasia. Thus Ki-67 
and p16 expression in pre malignant and malignant lesions of the cervix can be used 
in conjunction with the histo morphological features to study their proliferative 
potential. 
KEY WORDS: Ki-67, p16, CIN, Carcinoma cervix. 
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INTRODUCTION 
Carcinoma cervix is a major burden on the population and the government 
especially in developing countries like India, although its incidence has been 
controlled in developed nations. This decrease may be attributed to the efficacy of 
cervical cytology screening programmes which are done in a categorical manner. 
             Carcinoma cervix stands next only to breast cancers that affect the female 
population being responsible for about 5% of deaths due to malignancies 
worldwide
1
.  The estimated incidence of cervical cancer is 470,000 and remains as 
a leading cause of morbidity and mortality worldwide
2
. Approximately 230,000 
women die each year from cervical cancer; over 190,000 of these women are from 
developing countries. The contribution is roughly around 25% by the Indian 
women to the total occurrence in the world.
3
 
Biopsy cervix is definitive in establishing a diagnosis in cervical lesions. 
However, it has its own limitations such as the study of morphological parameters 
alone with no information as to the fate of the lesion (progression / regression). 
Further inter observer variability needs special mention.
4,5
 Hence to overcome 
these draw backs and to increase the accuracy in deciding the magnitude of 
progression, bio markers come into role. 
The carcinoma cervix has histopathologically, well characterized precursor 
lesions (CIN), which slowly progresses to the well differentiated tumour. The vast 
majority of HPV infections (up to 90%) regress spontaneously, without treatment, 
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after a few months. If the viral infection persists, however, the risk of developing a 
precancerous lesion increases as well as the risk of developing an invasive 
carcinoma.
6
 This transformation of cervical epithelial cells from CIN to carcinoma 
takes 10 – 15 yrs.7 During this transformation period , many important markers of 
tumor progression, are expressed.  
Carcinoma cervix, thus because of its long period of transformation,   
provides a great opportunity to study about the expression of biomarkers of tumor 
progression. Because of the above advantages, present study is designed to 
evaluate the mitotic count and the expression of immunomarkers, Ki-67 and p16 in 
different grades of cervical precancerous and cancerous lesions to understand their 
role in cervical carcinogenesis. 
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AIMS AND OBJECTIVES: 
1. To collect data on occurrence of cervical pre malignant and malignant 
lesions reported at TVMCH.   
2. To evaluate the proliferative indices in cervical pre-cancerous and 
cancerous lesions - mitotic count in haematoxylin and eosin sections 
and Ki-67 and p16 in IHC stained sections. 
3. To correlate the proliferative indices with varying grades of pre 
malignant lesions and various histological sub types of cervical 
carcinoma. 
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REVIEW OF LITERATURE 
EPIDEMIOLOGY OF CANCER CERVIX: 
Cervical cancer is one of the most common cancers among women 
worldwide (WHO 2009). Majority of cervical cancer cases today occur in the 
developing world. 
Approximately around 5 lakhs new cases of carcinoma cervix occur 
worldwide of which nearly 50% culminate in death.
1
 The incidence rate has 
declined in both white and African American women, for the past few decades. 
Since 2004, rates have decreased by 2.1 % per year in women younger than 50 
years of age and by 3.1% per year in women aged 50yrs and above. 
The Indian sub-continent has a considerable population of females in the 
reproductive age group who at risk of developing cervical cancer. According to the 
current statistics, around 1.25 lakh new cases that are diagnosed and 75000 deaths 
in our country  are due to cancer cervix.
2
 According to National Cancer Registry of 
ICMR the incidence in India is 14.42/100000 population with mortality rate 
2.83/100000 population (ICMR 2004). 
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ANATOMY OF CERVIX: 
The cervix (term taken from the Latin, meaning neck) is the continuation of 
the body of the uterus. The cervix is anatomically divided into portio vaginalis that 
protrudes into the upper vagina and supravaginal portion.  It has an anterior and a 
posterior lip. It is 2.5–3 cm in length in the adult nulligravida. In the anatomical 
position, it has a slight angulation.  
The portio vaginalis of the cervix is divided into three parts- endocervix, 
ectocervix, and the transformation zone.  
The Ectocervix is the portion of cervix which extends  from the  squamo - 
columnar junction to the vaginal fornices.  
The Endocervix is the portion of cervix which extends from the internal os 
to the ectocervix and it has the endocervical canal.  
The Squamocolumnar Junction (SCJ) denotes the region where the 
squamous epithelium of ectocervix and columnar epithelium of the endocervix  
meet. 
HISTOLOGY OF CERVIX: 
            The cervix has both columnar and squamous epithelial lining with the sub 
epithelium composed of ﬁbromuscular tissue with blood vessels which gives it the 
tough consistency. Smooth muscle occupies mainly the endocervix  and comprises 
15% of the substance. 
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Ectocervix: 
The ectocervix is lined by mature nonkeratinizing stratified squamous 
epithelium. 
It has three zones: 
1) Basal /parabasal cell layer, which is responsible for the continuous 
epithelial regeneration, hence otherwise called germinal layer 
2) Stratum spinosum, which lies between the basal and the superficial layer 
forms the major portion  
3) Superﬁcial zone, composed of mature cells   
 
Fig. 1. Histology of ectocervix showing orderly maturation 
The basal layer has two types of cells. The basal cell, which is about 10 nm 
in diameter, with very minimal cytoplasm and elongated nuclei placed 
perpendicular to the basal membrane which is beneath it.  
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The parabasal is called so because of its histomorphological position. 
Parabasal cells which are one-to-two-cells thick over the basal epithelium, are 
larger having more cytoplasm. These cells are mainly concerned with continuous 
regeneration. 
The midzone is occupied by cells undergoing maturation, characterized by a 
gradual increase in the volume of the cytoplasm but the nuclear size, however, 
remains the same up to the most superﬁcial cell level. Once exfoliated these cells 
are referred to as the intermediate cells. These cells do not undergo cell division. 
Intermediate cells have abundant intracellular glycogen, responsible for the clear, 
vacuolated appearance of their cytoplasm. 
The most differentiated compartment of the squamous epithelium is the 
most superficial portion composed of flat cells. The cells in this portion have 
abundant cytoplasm with condensed nuclei.  
During the reproductive period the epithelium of the ectocervix is under 
continuous remodelling by proliferation, maturation, and desquamation. The 
epithelium takes 4-5days for a cycle of regeneration to complete.  
Endocervix: 
The endocervical canal and the underlying glands are lined by mucin-
secreting, columnar epithelium. The columnar epithelial cells have granular 
cytoplasm filled with mucin and basally placed oval nuclei.  
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The subepithelium of the endocervical mucosa has a well-developed 
capillary network .True lymphoid follicles with or without formation of germinal 
centers, are occasionally seen in the subepithelial stroma of both the ectocervix 
and the endocervix.    
 
 
Fig.2. Histology of endocervix showing glands lined by mucinous epithelium 
 
There is another kind of ciliated cells, which are non secretory in nature 
present in the endocervix. The main function of these ciliated cells is that they help 
in distribution and mobilization of the endocervical mucus.
8
 The other types of 
cells that are seen in endocervical epithelium include argyrophil, neuroendocrine 
and argentaffin cells.
9
  These cells can be demonstrated by histochemical stains  
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Transformation zone: 
            The transformation zone is the junction between the stratiﬁed squamous 
epithelium of the ectocervix and the glandular epithelium of the endocervix. This 
is otherwise called the squamo columnar junction. This is constantly subjected to 
hormonal inﬂuences, and as a consequence, its anatomic location keeps varying 
with age.  
The importance of transformation zone is that it withstands the most 
important function of differentiation. This zone includes cells destined for both 
squamous and columnar cell differentiation. These changes /differentiation 
develops in response to inflammatory stimuli and alterations in pH that occur 
following the onset of menarche. They may be identified by basal/reserve cell 
markers. A generic biomarker that identifies all of these cells is p63. 
           Basal and columnar cells appear most susceptible to infection, based on the 
requirement that these cells be exposed to the virus for infection to take place. 
Presumably these cells contain receptors targeted by the papillomavirus. 
10 
 
 
Fig. 3. Picture showing microscopic appearance of squamo columnar junction 
At birth, female neonates have endocervical epithelium present in the portio 
which is because of intrauterine exposure to maternal hormones. But this rapidly 
keeps regressing into the endocervical canal until menarche. During puberty, 
pregnancy, or progesterone therapy, the presence of endocervical glandular 
epithelium in the ectocervix results in what is clinically known as physiologic 
cervical eversion or ectropion. 
          During the reproductive years, the endocervical epithelium is constantly 
replaced by metaplastic squamous epithelium. This is due to exposure of the 
ectropion to the acidity of the vagina and other environmental factors. The degree 
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of ectropion begins to decrease with increasing age and time from onset of sexual 
activity.  
           During menopause, this zone recedes, and in postmenopausal women may 
be located completely within the endocervical canal. Hence, the transformation 
zone is the remodelled area of ectropion which undergoes active squamous 
metaplasia and thereby represents the region between the original and the 
functional SCJ. 
          The transformation zone is a very dynamic area, which keeps changing 
under hormonal and environmental inﬂuences. Remodeling of the ectropion is not 
always in a uniform fashion, and, in fact, squamous metaplasia can, and often 
does, occur anywhere within the exposed endocervical columnar epithelium in a 
patchy fashion. This area is the one most susceptible to HPV infection for several 
reasons, including higher susceptibility of the advancing edge of the immature 
squamous epithelium to infection. 
CERVICAL INTRA EPITHELIAL NEOPLASIA: 
          It was during the beginning of this century that the existence of precursor 
lesions of carcinoma cervix was extensively studied. Sir John Williams was the 
first to comment on dysplastic changes in the epithelium seen in cases of frank 
invasive carcinomas in 1886.This was followed by description of the histological 
appearance of these intra epithelial lesions which had histological features similar 
to the adjacent invasive component. 
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           The recognition of many similarities between the cervical intra epithelial  
lesions and invasive squamous cell carcinoma led to confirmation of the 
hypothesis that invasive squamous cell carcinoma develops from a deﬁned intra 
epithelial lesion
10
. To add strength to this fact, many of the long-term follow-up 
studies, clearly demonstrated that a signiﬁcant proportion of patients with 
carcinoma in situ who were left untreated presented with invasive squamous cell 
carcinoma. 
           The World Health Organization (WHO) first proposed uniﬁed terminology 
to define and report cervical carcinoma precursor lesions in cervical biopsy 
specimens. Intra epithelial squamous dysplasia was thereby deﬁned as a “lesion in 
which part or whole of the thickness of the epithelium is replaced by cells showing 
varying degrees of atypia, and it was further divided into mild, moderate, and 
severe.  
Even then, there was no widely accepted criteria for separating the grades 
of dysplasia and the further separation of each lesion into one of the categories was 
highly subjective. The separation of dysplasia from carcinoma in situ implies two 
distinct disease processes rather than a spectrum of severity of what is now known 
to be a single disease process. 
 The terminology of CIN was similarly divided into three categories, CIN I, 
CIN II, and CIN III, with carcinoma in situ being incorporated into the CIN III 
category. Carcinoma in situ was further subdivided by some authors into parabasal 
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cell, keratinizing cell, pleomorphic cell , and small cell types which is of no 
significance.
11,12
  
The vocabulary of cervical intraepithelial lesions supposed to represent the 
precursors of invasive carcinoma, has progressed over the years and continues 
changing today.  
The basic principles are the following:  
1. Nearly all invasive carcinomas of the cervix are preceded by a stage in 
which the atypical cells remain confined to the epithelium 
(intraepithelial stage). 
2. These intraepithelial lesions share many of the cytologic features of 
the invasive carcinoma, which include nuclear enlargement, irregular 
nuclear membrane, hyperchromatic nuclei; increase in mitotic activity; 
and disorderly maturation pattern. There is also a diminution or 
absence of cytoplasmic glycogen which can be illustrated by the 
reduction or lack of staining with the Lugol iodine or Schiller test. 
3. A series of pattern of morphologic abnormalities  among these lesions 
provide a rough indication of the possibility with which they will turn 
into invasive carcinoma, if left untreated. These morphologic 
abnormalities inturn show correlation with immunohistochemical, 
cytogenetic, cellular proliferation, DNA ploidy and molecular 
changes. 
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4. It has been proven that in the large majority of cases, the process 
particularly affects the areas of squamous metaplasia located at the 
transformation zone and in its endocervical side and sparing the native 
squamous epithelium of the ectocervix. 
5. The microscopic criteria for the diagnosis of these lesions remains the 
same regardless of the situations. 
The lesions induced by HPV in the cervix can range anywhere between a 
condyloma to frank malignancy. Exophytic condylomata are less common in the 
cervical transformation zone. They are associated usually with HPV types 6  
and 11.   
 These lesions exhibit acanthosis, verruciform growth pattern, and viral 
cytopathic effect (koilocytotic atypia).
13
 The verrucous pattern is typified by blunt 
papillae. The superficial atypia is characterized by karyomegaly, nuclear 
enlargement with binucleation, irregularities in nuclear membrane, and 
hyperchromasia.    
          Metaplasia refers to replacement of one differentiated cell by another cell 
type. Though it serves as a protective mechanism to withstand tough conditions it 
may provide the initiative towards neoplasia. Likewise columnar epithelium of the 
endocervix also undergoes metaplasia to a stratified squamous epithelium. 
  This makes the epithelium particularly vulnerable to infections by the 
viruses, and other risk factors leading onto the development of an intraepithelial 
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neoplasm.  Differences in the differentiation level or differentiation pathway of the 
underlying mucosa may influence the morphologic presentation of cervical lesions, 
leading to additional patterns not accounted for in traditional classifications.   
           The impact of HPV infection on squamous epithelium can be summarized 
in two important histologic parameters:  
1. Alterations in the density of superficial epithelial cells. The persistence 
of a higher nuclear density manifested by either more nuclei per unit 
area or more nuclear area.  
2. Superficial squamous atypia. In mature SILs, the effects of HPV 
infection produce nuclear enlargement, variations in nuclear size, and 
binucleation.       
             The HPV induces a variety of squamous pathologies which can be a 
minimal lesion like flat condyloma to a highly invasive carcinoma. Flat 
condyloma, is a plaque lesion involving ectocervix with the transformation zone, 
with koilocytosis as the cardinal finding. The koilocytic atypia is recognized by 
cytoplasmic vacuolation
14
 around the nuclei with condensation of the cytoplasm at 
the periphery, nuclear atypicality include nuclear enlargement, hyperchromasia, 
chromatin clumping, marked nuclear membrane irregularities, and multinucleation. 
Condyloma can coexist with low or even high- grade CIN.   
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Table 1 : Older and Newer WHO terminology of CIN 
Older classification WHO classification 
Mild dysplasia CIN I 
Moderate dysplasia CIN II 
Severe dysplasia/carcinoma in situ CIN III 
 
 
 
  
 
 
 
 
Fig.4. Microscopic appearance of progressive stages: A-CIN-1,B-CIN-II and 
C-CIN-III 
The morphologic spectrum of CIN to frank carcinoma can be seen as a 
continuum.                   
       CIN 1 (mild squamous dysplasia) is defined as the presence of dysplastic 
squamous cells in the lower third of the epithelium along with HPV changes in the 
rest of the superficial epithelium. The presence of mitotic figures several cell 
layers above the basal membrane supports a diagnosis of CIN 1. The presence of 
atypical mitosis even at the basal level also attests the presence of dysplasia. 
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The features of LSIL in mature squamous epithelium include the following: 
1. Conspicuous superficial cell atypia with binucleation, two-fold nuclear  
enlargement, and variable nuclear chromasia.  
2. Generally low N/C ratio in maturing epithelial cells with preserved 
cytoplasmic differentiation.  
3. A subtle expansion of the lower third of the epithelium, signifying a 
mild delay in epithelial cell maturation.  
4. A range of nuclear features in the lower third of the epithelium that 
include either euchromasia or uniform hyperchromasia, with minimal 
variation in nuclear size and shape. Enlarged nuclei in the lower layers 
usually have minimal chromatin complexity and reside within cells 
undergoing cytoplasmic maturation.  
5. Generally well-preserved polarity with uniform transitions to mature  
epithelium. Exophytic lesions associated with HPV-6/11 will exhibit 
patchy or negative p16 staining. 
Most flat lesions will exhibit diffuse p16 staining in the lower epithelial layers. 
            CIN 2 (moderate dysplasia) is defined by presence of dysplastic squamous 
cells in the basal two-thirds of the epithelium; the remaining of the epithelium 
shows some differentiation with maturation, with, as in CIN 1. Nuclear 
abnormalities are more marked than in CIN 1, and more nuclei with greater 
degrees of abnormality are seen high in the epithelium. The diagnosis of CIN-II is 
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highly subjective to inter observer variability,
15
 but however its differentiation 
from CIN-I is clinically mandatory.               
              CIN 3 (severe dysplasia) is defined by dysplastic squamous cells marked 
throughout the whole thickness of the epithelium. Mitotic figures which are 
usually confined to the basal layers are found at all levels of the epithelium and 
may be numerous, with many abnormal configurations. The findings in the upper 
portion of the epithelium include more extensive nuclear changes. CIN-II and 
CIN-III are together considered high grade intra epithelial lesions. 
The features can be summarised as follows:  
1. In general, less maturation, higher nuclear density, and a less orderly 
transition from the immature to mature epithelial layers.  
2. Abnormal cell differentiation 
3. Greater differences in nuclear size and staining as well as contours and 
chromasia in the lower epithelial layers. In essence, these features reflect 
the effects of oncogenic papillomaviruses on the biology of the 
replicating (lower epithelial) cell layers.  
4. In addition to a broader distribution of nuclear atypia and loss of cell 
polarity, these lesions are distinguished to some degree from LSIL by 
increased mitotic index and abnormal mitotic figures. CIN-3 lesions 
(including carcinomas in situ) contain full-thickness nuclear atypia. 
However, the degree of variation in nuclear size, contour, and staining 
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may vary, giving rise to variants of CIN-3 that closely mimic immature 
metaplastic epithelium, with more subtle degrees of karyomegaly or 
anisokaryosis. Such cases may be difficult to recognize on both 
cytologic and histologic examination, and other strategies, such as the 
use of biomarkers, may be required in such cases. 
5. Changes usually attributed to the presence of HPV infection, such as 
koilocytosis and epithelial multinucleation, are often present and are 
most conspicuous in CIN1 and 2,and minimal or absent in CIN3.This 
may be a reflection of viral integration only in the high grade lesion. 
            High-grade cervical intraepithelial lesion should be distinguished from 
atypia of repair, radiation changes, atrophy, immature squamous metaplasia, 
transitional metaplasia and invasive squamous cell carcinoma.                   
             In atypia of repair, the squamous epithelium may be disorganized, atypical 
basal-like cells may be present up to the mid-zone, and there may be nuclear atypia 
with nuclear enlargement causing confusion with CIN.           
             However, in repair some maturation of the squamous epithelium towards 
the surface is made out with the cells having well-deﬁned cell borders that show no 
crowding. Further there is no variation in cell size or shape. There is no coarse 
chromatin but prominent nucleoli, and if cytoplasmic halos are present, they are 
small and uniform secondary to accelerated cell maturation.    
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Frequently, there is acute inﬂammation, spongiosis, and mitoses that are on 
fined to the parabasal layers of the epithelium. Ki-67 can be helpful in 
distinguishing SIL from reactive epithelium as staining should be conﬁned to the 
lower third of the epithelium in atypia of repair.  
            In cases where reactive changes can rarely coexist with CIN, a point in 
favour of the diagnosis may be the ﬁnding of nuclei with HPV effect in the 
superﬁcial layers.              
            Radiation changes can be distinguished from CIN both by an increase in 
the nuclear size and the amount of cytoplasm. Therefore, there is a proportionate 
or decreased nuclear-to-cytoplasmic ratio. Nuclear spacing is uniform with 
minimal nuclear crowding and the chromatin is smudgy, rather than coarse. 
Mitoses are rare and cytoplasmic vacuolization may be present.  
              Atrophic squamous epithelium may be seen in post- menopausal women 
or those on Depo-Provera. Distinguishing atrophy from CIN can be very difﬁcult 
as in cases where the epithelium lacks maturation; the cells have increased nuclear-
to-cytoplasmic ratio; and the nuclei are small with coarse and hyperchromatic 
chromatin. However, in atrophy, the nuclei are uniform in size and spacing, and 
there is minimal nuclear pleomorphism and absent to rare mitoses Ki-67 can be 
helpful in this distinction, as atrophy should show minimal to absent staining, 
while CIN  shows strong positive staining involving at least the upper two- thirds 
of the epithelium.  
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 Immature squamous metaplasia can also be difﬁcult to distinguish from 
CIN, as immature squamous cells with increased nuclear-to-cytoplasmic ratio may 
occupy almost the full thickness epithelium, and maturation may only be seen 
towards the surface. However, there is no cell crowding and, unlike CIN, cell 
membranes are usually well deﬁned. The nuclei are uniform in size and shape, 
they have ﬁne chromatin, and small nucleoli may be seen. Even though mitoses 
may be present, abnormal mitoses are lacking. Columnar cells may be present on 
the surface overlying the metaplastic epithelium but are only rarely present 
overlying dysplastic epithelium, and thus is a helpful feature.     
            Differentiating atypical immature squamous metaplasia from CIN is even 
more difﬁcult and sometimes not possible. The degree of nuclear atypia is usually 
less prominent than HSIL and although mitotic ﬁgures may be present, they are not 
abnormal, as they can be in HSIL. p16 immunohistochemistry may be useful in 
some of these cases.  
            Transitional metaplasia is seen predominantly in post- menopausal women 
where it can involve the transformation zone, the ectocervix as well as the vagina. 
It can be misdiagnosed as high grade CIN since this lesion is more than ten cell 
layer in thickness with absence of maturation and elongated nuclei exhibiting 
irregular nuclear contours. The differentiating features include very occasional 
mitoses, horizontal orientation of the cells in the superficial layer which show 
streaming and oval nuclei with fine chromatin and grooving. However, this 
condition can be present in conjunction with dysplastic changes. 
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RISK FACTORS ASSOCIATED WITH CIN AND CARCINOMA CERVIX : 
            The risk factors associated with the development of carcinoma cervix can 
be broadly divided into two: 
1. Viral 
2. Non-viral       
The non-viral factors include: 
1. Age  
2. Immune status 
3. Multiple sexual partners 
4. Oral contraceptives 
5. Other associated infections 
Virus as risk factor: 
            The first human cancer to be found to have infectious agent as a causative 
factor is the cervical cancer. (Thomson et al 2008.) The human papilloma virus 
infection is the most important risk factor of cervical cancer
16
. Almost all of the 
invasive cervical cancers are preceded by cervical intraepithelial neoplasia (CIN) 
induced by HPV. Not all HPV related lesions present as condyloma or low-grade 
lesions; high-grade lesions may appear at any point of the infection depending on 
HPV types and quantity. 
            Human papilloma virus has nearly 150 types which are classified into high 
risk, probable high risk, and low risk
17
.                
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The low-risk subtypes include HPV 6, 11, 42, 43, 44, and 53. 
The High- risk subtypes include HPV16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 
58, 59, and 68.  The high risk type of HPV and its persistence is the most 
important of all.
18
 However, viral load will not discriminate low- from high-grade 
CIN because viral production is often higher in low-grade lesions.  
          The human papilloma virus enters the basal cells or immature squamous 
metaplastic cells through defects in the mucosa at the transformation zone. It 
usually infects the squamous epithelium; however, the virus can also infect 
subcolumnar reserve cells.  
         The virus can induce either a latent or a productive infection. In the 
productive infection, large amounts of free DNA virus are produced in the 
intermediate and superﬁcial cell layers, which are considered nonproliferating 
terminally, differentiated squamous cells. As the virally infected cells mature and 
move towards the surface, the characteristic cytopathic effect – the so-called 
koilocytic atypia – becomes apparent.         
         Incorporation of HPV DNA into the host cell genome, with covalent binding 
of viral genome into host DNA, is considered a critical event in the progression to 
high-grade cervical intraepithelial lesions. 
          High-risk HPVs induce changes in the epithelium by producing E6 and E7, 
two proteins that have significant growth-stimulating and transforming properties. 
As the virus gets integrated with the host genome, there is enormous expression of 
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E6, E7 due to disruption of the viral DNA
19
. This excess in the levels of E6/E7 
proteins leads to down regulation of p53/Rb which are tumor suppressor proteins 
with the end result being uncontrolled cell proliferation with dysplastic  
changes.
20,21
          
It has been found in various studies that low-risk HPV is almost always 
associated with low-grade cervical intraepithelial neoplasia which frequently 
regresses, and its association with cervical carcinoma is exceedingly rare, whereas 
high-risk HPV subtypes can result in either low or high grade lesions. Moreover, if 
left untreated, it subsequently progresses to invasive carcinoma.   
HPV-16 is detected in nearly 50% of HSIL and squamous carcinomas of the 
cervix and is the “prototypic” cancer-causing virus. HPV-18 is associated with less 
than 15% of squamous carcinomas, predominating in adenocarcinomas in situ and 
invasive adenocarcinomas. 
    HPV testing has been approved for cervical cancer prevention, keeping the 
following in mind:  
HPV testing combines high sensitivity and an objective measurement of 
cervical cancer or precursor risk, and the increase in risk attending its presence is 
approximately 40-fold.  
 Combined negative HPV testing and normal smear may increase the 
duration  of the “protective effect.” Because HPV is detected prior to 
the development of a cytologic abnormality, it is likely that patients 
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negative by both HPV testing  and smear may be followed at longer 
intervals than by smear alone.  
 The index of HPV positivity drops markedly over age 30, and this group 
has been selected for screening. The degree to which an HPV test is 
more specific for neoplasia risk in this group varies according to the 
study.  
 A significant fraction of menopausal women may score positive for 
HPV,  A number of studies have emphasized the importance of HPVs 
16 and 18, the two most prevalent HPVs in cervical cancer 
Non-viral risk factors: 
Age :  
  Young, sexually active women are at greatest risk for HPV infection and  
preinvasive cervical neoplasia. This risk gets reduced significantly with increasing 
age, which is associated with decreasing risk of cancer. The risk is reduced with 
the attainment of menopause. The progressive drop in risk with increasing age can 
be attributed to an effective immune response against the virus that follows the 
onset of sexual activity and exposure to HPVs. Protection is long lasting, given the 
low rates of HPV positivity in middle-age women. 
HLA type:  
HLA that belongs to class II haplotypes (linked class II alleles) are 
generally related to cervical intraepithelial neoplasia and invasive carcinoma. 
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Among this certain class II alleles are related to LSIL, HSIL, and full blown 
malignancy, but certain other type II alleles  are protective in nature.
22 
Still others 
have been associated with infection alone or certain HLA types are associated with 
cancers produced by certain HPV types, such as type 16. The studies observed that 
specific HLA class II haplotypes may influence HPV antigen presentation and the 
immune response to HPV infection, in turn influencing the risk of developing 
invasive cervical carcinoma. 
Immune status :  
Immunodeficiency conditions like HIV infection, post transplantation,
23 
those on immunosuppression drugs have increased risk of developing cervical 
carcinoma. The reason is there is deficient cell mediated immunity and therefore 
increased risk of cervical cancer.
24
 The impact of HIV infection on cervical cancer 
risk is controversial, but prognosis appears worse in patients with severe 
immunodeficiency. 
             The risk of cervical neoplasia or HPV infection in immunosuppressed 
individuals is well documented. Cancer rates are higher in this population, and in 
general anogenital cancers occur at a younger age. 
             HIV-infected individuals are particularly prone to persistent HPV 
infection, and a higher risk of precursor lesions. The prognosis of cervical cancer 
in HIV infection appears to be worse due to severe immunodeficiency. The rate of 
the virus infection in the immunosuppressed patients were found to be increased 9 
folds when compared to the general population. 
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The risk of HPV positivity is increased in women who are HIV positive
25
 
Approximately 60% of HIV-infected women versus 36% of uninfected women 
score positive for HPV, based on testing of cervical samples. Frequencies of  
HPV-16, HPV-18, and multiple infections are also significantly more common in 
the HIV-infected group. The risk of a subsequent squamous intraepithelial lesion is 
also significantly higher in HIV-infected women.
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Multiple sex partners:  
It has been proposed that if the male partners have multiple sexual partners, 
it influences the risk of cancer development, even though it is of lesser degree. 
Krebs and Helmkamp showed that treating the male partner did not influence risk 
of recurrent genital warts. The implication of this study is they are not reinfected 
by the same virus, which is in consistence with a functioning immune system. 
Condoms protect against HPV infections, but incompletely. Circumcision reduces 
the risk of infection in the male partner and his female contacts.  Moreover, timing 
of sexual activity gains more importance than absolute number of sexual partners 
in conferring risk of current HPV infection.  
Oral contraceptives: 
The use of oral contraceptives has shown to have increased risk for the 
development of carcinoma cervix. The strong theoretic basis for this is the 
hormones influencing epithelial growth which increases the susceptibility to 
neoplasia in the cervical transformation zone
27
.  
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Oral contraceptive use with their plasma levels has a linear association with 
cervical neoplasia
28
. Indeed there is a strong association between hormonal 
replacement and cervical adenocarcinoma. A recent meta-analysis postulated a 
relative risk of 1.90 with use of oral contraceptive pills for greater than 5 years and 
a decline in risk with cessation of use.
29
.  
Smoking: 
Smoking increases the risk of cervical neoplasia, however the mechanism is 
unclear. The reason behind this is presumably the presence of DNA adducts in the 
cervical mucus, thereby exposing the transformation zone mucosa to 
carcinogens.
30
 Genetic polymorphisms that theoretically do not reduce adduct 
formation have also been implicated. There is also a dose- response relationship 
between the two.  
Other associated infections: 
          The association between chlamydia infection and cervical neoplasia is 
controversial. There is evidence that infection with chlamydia serotype G confers a 
significant risk of cervical cancer.
31 
There are several studies showing a 
relationship between genital infections and HPV or CIN. 
          In summary, a multitude of factors, viral and host related, influences risk of 
cervical neoplasia before, during, and following exposure and lesion progression. 
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CARCINOMA CERVIX: 
         The World Health Organization (WHO) divides invasive carcinoma of the 
cervix into three categories :  
 squamous cell carcinoma  
 adenocarcinoma and  
 other epithelial tumors  
           The „„other epithelial tumors‟‟ include  
 adenosquamous carcinoma  
 adenoid basal cell carcinoma  
 adenoid cystic carcinomas  
 neuroendocrine tumors and  
 undifferentiated carcinoma            
          Squamous cell carcinoma of cervix is the most common histological variant 
followed by adenocarcinoma and adenosquamous carcinoma.  
Precautions to be considered before reporting carcinoma cervix: 
1. Excluding non-neoplastic infections, such as herpes or chlamydia 
2. Understanding the transformation zone and the plethora of benign 
alterations in epithelial differentiation that characterize this region  
3. Applying the criteria for differentiating grades  of CIN  
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4. Understanding the influence of transformation zone epithelial subsets on 
the morphology of type-specific infections in the transformation zone, 
producing patterns that do not conform to classic descriptions and less 
easily classified lesion patterns 
5. Having a working knowledge of the differential diagnosis of classic and 
variant forms of SIL 
MICRO INVASIVE SQUAMOUS CELL CARCINOMA:  
This is also called early invasive carcinoma of cervix. This tumor lies in the 
spectrum between CIN and well established invasive carcinoma. This is defined as 
tumor less than or  equal to 3mm in depth and 7mm in length without capillary or 
lymphatic invasion. Practically almost always associated with high-grade CIN, 
these are small irregular nests of dysplastic epithelial cells that are either highly 
atypical or individually keratinized. 
Diagnosis of MICA can be made only by histopathological examination.  
The criteria for diagnosis include desmoplastic reaction of the stroma, well 
matured squamous cells, with loss of polarity and necrosis within the lumen. 
Common age at presentation falls between 35 – 46 yrs. It amounts to about 20% of 
all cancers of the cervix. 
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Important parameters in microinvasive carcinoma: 
Tumor type :   
        Certain subsets of squamous carcinoma, such as papillary squamous 
carcinomas, may not be as easily evaluated without complete excision.  
Confluence of Growth Pattern : 
         Confluence has been defined as anastomosing tongues of epithelium with 
pushing borders or a lesion front of greater than 1 mm. 
Capillary-Lymphatic Space Invasion: 
       The majority of cases with CLSI do not present with histologically positive 
lymph nodes, but CLSI is associated more commonly with an adverse outcome. 
INVASIVE SQUAMOUS CELL CARCINOMA : 
         Carcinoma cervix is more common in women in their fourth or fifth decade 
though cases have been reported in all age groups above fifteen. The age group in 
which malignancy prevails is higher by nearly twenty years when compared to that 
of high grade intra epithelial neoplasia. However more of cases reported today are 
less than 30 years of age. 
The clinical presentation of patients with invasive carcinoma of the cervix 
depends on the size and stage of the lesion .During the earlier periods, the patients 
presented with bulky masses since they had a very late diagnosis. Nearly all of 
them presented with clinically visible tumors and with complaints of profuse 
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vaginal bleeding. The other manifestations include spotting per vaginum, 
serosanguinous discharge, and frank bleeding . 
The following features aid in the diagnosis of invasion: 
 a desmoplastic response in the adjacent stroma.  
 focal conspicuous maturation of the neoplastic epithelium with 
prominent nucleoli. 
 blurring of the epithelial-stromal interface 
 loss of polarity of the nuclei at the epithelial-stromal border with 
absence of the palisaded pattern characteristic of CIN  
 scalloping of the margins at the epithelial-stromal interface  
 the appearance of pseudocrypt involvement  
 the apparent “folding or duplication” of the neoplastic epithelium  
Duplication of epithelium refers to the presence of vascular structures 
within a sheet of neoplastic epithelial cells, producing an image of incompletely 
formed papillae  
             Cervical carcinomas metastasise locally into the cervical stroma, the 
paracervical and parametrial tissues, the body of the uterus, the vagina, the pelvic 
nodes and late in the course of the disease to the bladder and rectum.                             
            Microscopically, overt invasive squamous cell carcinomas usually display 
considerable morphologic heterogeneity in growth pattern, cell type, and degree of 
cellular differentiation. However many are characterized by sheets and nests of 
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squamous cells invading into the stroma which shows a desmoplastic change. The 
tumor cells can also occur in single or in large masses entirely replacing the 
stroma.                        
The individual cells are polygonal with abundant cytoplasm and 
pleomorphic nuclei with coarse chromatin and prominent nucleoli. The mitotic 
figures are usually increased and the stroma may show infiltration by 
inflammatory cells. 
Invasive squamous cell carcinomas are divided into two groups, 
1. keratinizing   
2. nonkeratinizing                  
 Keratinizing carcinomas are characterized by the presence of well 
differentiated squamous epithelial cells that vary in size and conﬁguration, arranged 
in nests or cords. The keratinizing carcinomas are deﬁned by the presence of 
keratin pearls within the epithelium and the presence of a single keratin pearl is 
sufﬁcient to classify as a keratinizing carcinoma. Keratin pearls are clusters of 
squamous cells arranged in a concentric nest, that have undergone keratinization . 
Nonkeratinizing squamous cell carcinoma is characterized by nests of 
neoplastic squamous cells that do not form keratin pearls but frequently undergo 
individual cell keratinization with numerous mitotic ﬁgures. The cells have 
relatively indistinct cell borders and round to oval nuclei with coarsely clumped 
chromatin . 
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Fig.5. Microscopic appearance of well differentiated squamous cell 
carcinoma with keratin pearls 
 
MICROSCOPIC GRADING OF SQUAMOUS CELL CARCINOMA:  
Squamous cell carcinomas are graded histologically as follows:  
1. Grade I   -Well differentiated  
2. Grade II  -Moderately differentiated   
3. Grade III - Poorly differentiated   
Of the three, the most commonly occurring tumor belongs to grade II, 
moderately differentiated squamous cell carcinoma. Next frequent tumor would be  
grade III( poorly differentiated ), followed by grade I (well differentiated)  . 
Well-differentiated squamous cell carcinoma:  
This carcinoma is characterized by the presence of keratin pearls and 
individual cell keratinisation with prominent intercellular bridges. The tightly 
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packed cells have irregular , hyperchromatic nuclei with mitosis seen at the 
advancing  margin of the tumor and the stroma showing inflammatory reaction 
with occasional giant cells of foreign body type as a reaction to the keratin.  
Moderately differentiated squamous cell carcinoma:   
           The grade II tumor cells are large with indistinct cell margin and  
intercellular bridge with increased nuclear cytoplasmic ratio and irregular nuclei 
showing moderate degree of pleomorphism. Keratin pearls are absent. Tumor cells 
may show individual cell keratinization with increase in mitosis.     
 Poorly differentiated squamous cell carcinoma :                            
The tumor cells show high degree of pleomorphism with very scant 
cytoplasm and oval, hyperchromatic nuclei. Occasional giant cells with bizarre 
nuclei can be seen and there is total absence of keratinisation with heavily 
increased mitotic rate and focal areas of necrosis. Rarely the tumor cells can be 
spindle shaped.  
VARIANTS OF SQUAMOUS CELL CARCINOMA :  
Verrucous carcinoma  
It is a rare variant, which is considered a highly differentiated type of 
squamous cell carcinoma .On gross it appears to be polypoid in nature, and has an 
extremely well-differentiated cytologic appearance. Some cases have been found 
to extend into the endometrial cavity.
32
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Spindle cell carcinoma (sarcomatoid carcinoma; squamous cell carcinoma 
with sarcoma-like stroma; carcinosarcoma)   
The tumors frequently contain both squamous carcinoma and spindle cell 
components, either separate or subtly blending. They may contain osteoclast like 
giant cells, and there is often evidence of HPV infection.
33,34
 The epithelial 
component of this tumor, when present, is usually of squamous type.      
Basaloid (squamous cell) carcinoma  
Basaloid carcinoma is characterized by prominent peripheral palisading, an 
infiltrative growth pattern, and minimal stromal reaction.
35
 This tumor is 
aggressive and the differential diagnosis for this are the adenoid cystic carcinomas 
and adenoid basal carcinomas.   
Lymphoepithelioma-like carcinoma   
Lymphoepithelial-like carcinomas, which consist of poorly defined 
aggregates of nonkeratinized tumors cells, often with indistinct cytoplasmic 
borders, intermixed with abundant lymphoid cells, are similar to their morphologic 
counterparts in the pharynx.
36
  
Transitional cell (urothelial) carcinoma  : 
This lesion has an appearance similar to the tumor located in the bladder or 
ovary . It needs to be distinguished from inverted transitional cell papilloma and 
papillary squamous cell carcinoma.
37
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Important parameters in squamous cell carcinoma: 
Reporting Squamous Carcinomas Histologic reporting should include the 
following:    
 Grade (well, moderately, or poorly differentiated)  
 Cell type 
 Depth of invasion or thickness   
 Extent of tumor: the extent of invasion into extracervical tissues and 
metastases to both pelvic and extrapelvic organs should be recorded 
 Invasion into the vessels and lymphatics                 
 The total number of nodes removed with how many being involved by 
metastases  must be reported 
 If the clearance given is adequate by careful examination of the 
resection margins.                  
ADENOCARCINOMA: 
Primary adenocarcinomas make up 5–15% of all carcinomas of the cervix. 
The occurrence of adenocarcinoma of the cervix is on the rise in relation to 
squamous carcinoma.
38
 Not all adenocarcinomas are associated with HPV. There 
are several different subtypes of adenocarcinoma, possibly with different etiologies 
and natural histories. Since these carcinomas have a tendency to grow 
endophytically they are diagnosed only very late. Further the tumor has a worser 
prognosis compared to squamous cell carcinoma. 
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Incidence is on the rise in the general population, particularly in young 
women. An association has been found between the long-term use of oral 
contraceptives and the development of endocervical neoplasia in young patients. 
Young age and exposure to HPV are other risk factors. Unresolved, however, is 
the mechanism by which these events increase the risk of glandular neoplasia 
relative to squamous neoplasia.  The tumor shows no characteristic distinguishing 
gross features.  
ADENOCARCINOMA IN SITU :  
Though it predominantly involves the endocervix, the transformation zone 
is never spared. It has continuation with the overlying epithelium and invades the 
stroma widely. It is also usually associated with intra epithelial lesions. Rarely AIS 
initially develops high in the canal or is multifocal.
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The neoplastic glands are lined by stratified columnar cells that are oriented 
vertical to the basal layer. The basally located nucleus is oval, and hyperchromatic 
with mild pleomorphism . 
EARLY INVASIVE ADENOCARCINOMA: 
       Assessing early invasion in glandular lesions is some- times difficult because, 
unlike squamous lesions, preservation of AIS-like gland architecture may 
accompany invasion. Conversely, AIS itself may be quite complex. Thus, it is 
generally not advisable to diagnose early invasion from small biopsies. It is wise to 
have a larger one. 
39 
 
           The subtypes include  
o endocervical  
o endometroid                    
o intestinal   
o tubal                    
o stratified  
         It does not show desmoplastic reaction though inflammatory cells can be 
seen.   
Hence the features to make a diagnosis include: 
 Epithelial cell crowding- This occurs with stratification or pseudo 
stratification. 
 Nuclear enlargement- Nuclei are variably enlarged and are oval, 
elongated, or irregular  
 Prominent nuclear hyperchromasia with chromatin coarsening- Nucleoli 
are usually small or absent but may be prominent in some cases  
 Mitotic figures -  These are invariably present, often easily visualized at 
the luminal pole of the cell,  but there may be as few as one or two per 
five high-power fields. 
 Apoptotic bodies - One should require a definitive eosinophilic body 
containing sharply delineated dark fragments of chromatin so as not to 
confuse degenerated leukocytes with apoptotic bodies    
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 Conspicuous architectural alterations-These sometimes include papillary 
or cribriform intraglandular growth and may be quite florid, suggesting 
invasive carcinoma. 
Adenocarcinoma in situ is associated with CIN in at least 50% of cases and 
is immunoreactive for carcinoembryonic antigen in 80% of cases.
40
   
INVASIVE ADENO CARCINOMA: 
          There are three patterns of invasion that characterise adenocarcinomas, and 
all of them may be seen in early neoplasms. They are  
i. Infiltrative : 
            Its earliest manifestation is characterized by small protrusions into the 
stroma that appear to bud from AIS glands, often with an accompanying 
inflammatory response. The cells  of the buds and the early invasive glands are  
often larger than the AIS cells, with large nuclei, sometimes prominent nucleoli, 
and an expanded eosinophilic cytoplasm. The architectural pattern of adjacent 
benign glands provides a useful comparison. 
ii. Expansile : 
Here, well-circumscribed, AIS-like glands expand into the stroma as a 
compact unit rather than as separate infiltrative glands. Often there is no stromal 
reaction. This pattern, when it extends deeply enough, is recognized intuitively as 
invasive carcinoma. 
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iii. Exophytic : 
This invasive pattern refers to surface polypoid or papillary growth that is 
more pronounced than the small papillary excrescences that are sometimes present 
with AIS (Fig. 14-41). Invasion of the underlying stroma may or may not be 
present. 
Microscopically, the most common pattern is that of a well-differentiated 
glandular pattern with mucin secretion, some of which can leak into the stroma. 
 
 
 
 
 
 
 
 
Fig. 6. Histologic appearance of well differentiated adeno carcinoma 
 
VARIANTS OF ADENOCARCINOMA: 
The variants include: 
 Endometriod 
 Serous(papillary) 
 Clear cell 
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 Adenoid cystic 
 Mucinous 
 Villo glandular 
 Adenoid basal 
 Mesonephric adeno carcinoma       
NEURO ENDOCRINE CARCINOMA OF CERVIX:          
Small cell neuroendocrine carcinoma is morphologically similar to the 
classic oat cell carcinoma of the lung which has many of the following features: 
 uniform cell population  
 hyperchromatic nuclei 
 a high nuclear–cytoplasmic ratio   
 tumor cells arranged in irregular aggregates, often with little cohesion  
and        
 occasional rosettes or poorly defined acini.  
         In addition, the nuclei contain coarse to opaque chromatin and, because there 
is little cytoplasm, they often appear to “mold” with adjacent nuclei. These tumors 
may also extensively infiltrate the underlying cervical stroma. 
PROGNOSTIC PARAMETERS IN CARCINOMA CERVIX:  
The prognostic parameters include the following:  
 clinical staging  
 size of the tumor 
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 depth of invasion  
 age of the patient  
 lymph node metastases   
 parametrial extension 
 Among them, the most significant one is the clinical staging of the tumor.  
Staging of the disease:  
The clinical staging of the disease at the time of diagnosis is an important 
prognostic factor and it determines the survival of the patient.  Generally stage I 
has better survival rate. In stage I disease, there is difference in survival rate 
between IA and IB. Patients belonging to stage IA has 5-yr survival rate of 95% 
which gets reduced to about 80% - 90% in patients with stage IB. (Annexure-II) 
Survival rate gets reduced to about 75% in cases with stage II and lower to 
50% for stage III. Stage IV patients usually presents with local metastasis to 
adjacent kidney, bladder, urethra, at the time of diagnosis. So the survival of these 
patients is generally reduced and they die of complication due to local metastasis.  
Histological type :  
Poorly differentiated carcinoma and small cell carcinoma have bad 
prognosis than other types. The 5 year survival rate of adenocarcinoma is 10% 
lower than that of squamous cell carcinoma.   
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Size of tumor:  
         Generally, smaller the size of  tumor better the prognosis. The 5-yr survival 
rate of tumors of size less than 3 cm is about 86%. Tumors of size 3-5 cm has 5 yr 
survival rate of about 76% and for tumors of size larger than 5 cm ,the 5-year 
survival rates is around  61.5%.  
Depth of stromal invasion :  
It is the distance to which tumor has extended into the stroma and measured 
from the basal layer of the epithelium to the deepest point of tumor  extension. 
With increase in the depth of invasion, there is a high chance for the parametrial 
extension, lymph node metastasis  and recurrence. The stroma free of tumor serves 
as a barrier  to the spread of tumor.
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Lymphovascular invasion:  
The lymphovascular invasion is defined as the presence of tumor mass 
within any space lined by endothelial cells and adherence of tumor cells to the 
endothelial cells.
42
 When the depth of invasion is more, there is increased chance 
for the occurrence of lymphovascular invasion. LVSI is related with decreased 
survival rate and  increased risk of recurrence.  
Parametrial involvement :  
The parametrium is infiltrated by tumor cells either by contiguous spread 
and to lesser extent from lymphatic spread. Survival rate of stage I and II cancers 
is 90% without parametrial involvement, which gets reduced to 77% with 
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parametrial involvement.
42
 Involvement of parametrium with tumor shows high 
incidence of lymphnode metastasis, blood vessel invasion, tumor recurrence and 
increased mortality.  
Nodal status :  
The metastasis of lymph node depends on several factors like clinical 
staging, size of tumor, distance of stromal invasion, lymphovascular invasion and 
grade of tumor.
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 As the tumor advances to stage III and IV, there is increased 
chance of lymph node metastases.  
The cervical cancer spreads to obturator, paracervical and external iliac 
nodes. Pelvic node metastasis carries worse prognosis. Rarely there is involvement 
of para-aortic lymph nodes and if present it indicates dissemination of cancer. In 
the presence of pelvic lymph node metastasis, the 5 yr survival rate is observed to 
be reduced.      
Mitotic figures in dysplastic and malignant lesions of the cervix: 
          The stratified squamous epithelium of the ectocervix is so programmed that 
it undergoes an orderly maturation from the basal to the most superficial layer. The 
changes that can be seen from bottom to top include condensation of nuclei with 
increase in chromatin density and increase in the amount of cytoplasm due to the 
accumulation of glycogen. 
The parabasal cells in the epithelium serve the function of active 
proliferation and hence the mitotic activity is predominantly confined to the lower 
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two third of the epithelium. These mitotic figures can be studied in various aspects 
such as their distribution, normal or abnormal and density to understand the 
proliferative potential of the lesion. Also these elements can be demonstrated by 
immuno histochemistry. Their major application in pathology lies in distinguishing 
low grade from high grade intra epithelial lesions and to differentiate high grade 
dysplasia from other mimickers like atrophy and immature metaplasia. 
The occurrence of increased numbers of mitotic figures in dysplasias and 
carcinoma in situ have been mentioned by several. But there are no reports dealing 
with their exact frequencies. 
IMMUNOHISTOTECHNIQUES : 
Immunohistochemistry is one of the ancillary techniques that helps in 
identifying the tissue of origin on the basis of antigen antibody reaction. The 
antibody that is bound can be identified by labelling it either directly or by using 
another antibody i.e. secondary antibody. These antibodies have significance in 
that they serve as both prognostic and predictive markers. 
            The success of this technique lies in the accurate localisation of the 
antibody that has combined with the antigen and its precise visual identification. 
This is mainly done by amplification that multiplies the signal so that it is easy to 
visualise. At the same time there must not be any interference from the background 
staining. Immunohistochemistry helps the pathologists to fit the tumor, that has 
been  classified as undifferentiated in histology , into a specific histogenetic origin. 
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Fixation and Other Pre-Analytical Factors  : 
Autolysis is the process of self destruction by enzymes within the cellular 
organelles. The primary aim of fixation is to retard this process so that the internal 
architecture is preserved. 
There are many fixative recipes, but most of these can be grouped into three 
main categories as per the constituents as those that contain formalin, alcohol or 
both. 
Tissue Processing: 
It is the process during which the sections are passed through increasing 
grades of alcohol from 70 to 100% to remove water from the section .This is 
followed by wax impregnation which removes the alcohol. Waxes with low 
melting temperature (45 °C ) give better staining results for IHC. The sections are 
then embedded in paraffin.   
Section Preparation: 
Sections of 3-5 micron thickness are preferred. They are preferably cut 
using a fresh blade. The sections are thin so that they are not washed out during 
antigen retrival Further thick sections hinder with staining due to multiple layers.  
Coated slides are available to aid in firm attachment of the section to the 
slide. They are positively charged so that they firmly attach to the tissue proteins 
that are negatively charged. Sections must be firmly adhered to the glass to prevent 
lifting during staining or bubble formation, which may trap staining reagents.  
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Antigen Retrieval: 
Antigen retrieval by heating is an imporrtant step in IHC. When the sections 
are heated to a high temperature, the tissue proteins are subjected to hydrolysis 
which breaks the cross links thus exposing them for the antibody to bind. For 
many antigens, almost any kind of heating treatment, including microwave oven, 
water bath, pressure cooker, or autoclave may generate similar results, if adjusted 
appropriately for time. 
The pH value of the AR solution is another factor that significantly 
influences the results. A higher pH AR solution, such as Tris-HCl or sodium 
acetate buffer at pH 8.0-9.0, may be suitable for most antigens .  
Antibody: 
             Antibodies belong to the class of serum proteins known as 
immunoglobulins.  
They are found in blood and tissue fluids, as well as many secretions. The 
basic unit of each antibody is a monomer. An antibody can be monomeric, 
dimeric, trimeric, tetrameric, or pentameric.  
The antibodies used can be: 
               1. Polyclonal 
               2. Monoclonal 
 
 
49 
 
Production of polyclonal antibodies: 
Polyclonal antibodies are produced by immunizing an animal with a 
purified specific molecule (immunogen) which has the antigen of interest. The 
animal will mount a humoral response to the immunogen and the antibodies so 
produced will be a combination of many clones of activated plasma cells. The cells 
of each clone vary particularly in their specifity to the different epitopes that are 
expressed by the immunogen.    
Synthesis of monoclonal antibodies: 
The principle behind the production of monoclonal antibodies uses a 
combination of two properties- one is the ability to produce a specific antibody by 
an activated B lymphocyte or plasma cell and the other being the immortal 
property of malignant myeloma cells. These cells can be cultured in appropriate 
medium to multiply in huge numbers. This is referred to as the hybridoma 
technique. 
Antibody-antigen binding: 
              The antibody combines with the epitope of the antigen by means of amino 
acid side-chains which are complementary to each other. The combination of an 
antibody with an antigen requires high specificity. The interaction between the 
antibody and the antigen can be either alone or a combination of hydrogen bonds, 
electrostatic interactions, and van der Waals‟ forces. 
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Enzyme labels: 
Enzymes as labels have a wide application in immunohistochemistry such 
as  in blocking unwanted background staining and as chromogen that gives a 
coloured product so that it can be easily visualised by light microscope. The 
enzyme that is usually used is the Horseradish peroxidase in conjunction with the 
most favoured chromogen, i.e. 3,3α-diamino benzedene tetrahydrochloride (DAB), 
This is preferred because it gives a crisp, stable, dark brown end-product. 
If the coloured reaction products are miscible with alcohol,mounting should 
be done in an aqueous medium.  
Blocking background staining: 
The major causes of background staining in immunohistochemistry are the 
hydrophobic and ionic interactions and endogenous enzyme activity. Background 
staining may be specific or non-specific due to the apparent affinity of certain 
tissue components. Non-specific uptake of antigen, particularly the high affinity of 
collagen and reticulin for immunoglobulins, can cause high levels of background 
staining.                           
One of the ways to minimise this staining is to add an innocuous protein 
solution  to the section before applying the primary antibody. The added protein 
should saturate and neutralize the charged sites, thus enabling the primary antibody 
to bind to the antigenic site only. 
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The blocking of endogenous enzymatic activity must be carried out before 
the addition of enzyme-labelled secondary reagent; otherwise, the enzyme label is 
also inactivated by the blocking procedure, resulting in a false- negative result.         
As already mentioned the antibody molecules that take part in this reaction 
cannot be seen with the light microscope or even with the electron microscope 
unless some chemical in the name of labels or flags is used for their visualisation. 
Hence the detection systems tag labels or flags to primary or secondary antibodies 
to visualize the target antibody antigen localization. 
Washes: 
To prevent the formation of antigen-antibody complexes that will 
precipitate onto the sections and give rise to problems with interpretation and 
back- ground staining, it is necessary to remove the unbound antibody before 
incubation in the next layer. This is achieved by washing the sections in  
Tris-buffered saline (TBS). This solution may be made up in bulk for convenience. 
For routine work, a few brief washes, with TBS, will usually suffice.  
PRECAUTIONS  
1. The glasswares used should be dry and clean.  
2. All the buffers used should be prepared fresh  and the  pH should be 
adjusted according to the preferred pH.  
3. The staining procedures are never allowed to dry so they are performed 
under a humidity chamber.  
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4. DAB chromogen should be handled and disposed carefully as it is a 
carcinogen.  
5. Primary and secondary antibody, DAB chromogen, peroxidase block, 
and amplifier must be stored at 4-6ºC  
6. While performing IHC every batch should have a positive control slide.  
Ki-67 AND p16 AS BIOMARKERS IN CARCINOMA CERVIX: 
Ki-67:  
          Ki-67 is a nuclear protein that is expressed by multiplying cells in all the 
phases  of cell cycle(G1, S, G2, M) except G0.It can predict the possibility of 
development a tumor and so is called a  proliferation marker. The level of Ki-67 
expression is used to determine the cell proliferation status
43,44
. Its expression is 
usually seen in a normal mucosa and the lowermost layer of the epithelium. 
However when it shows positivity in the rest of the layers it implies disordered 
maturation. 
          Although Ki-67 has been used as a diagnostic adjunct for the classification 
of cervical tissue specimens
45,46
, the expression of Ki-67 alone does not 
discriminate HPV-mediated dysplasia versus benign proliferating cells in benign 
reactive processes.  
P16: 
p16INK4a, a cyclin-dependent kinase is a tumor-suppressor protein. Its 
action  of inhibition is by blocking cdk4- and cdk6-mediated phosphorylation of 
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Rb gene which in turn down regulates E2F-dependent transcription. Since this 
transcription has an essential role in cell-cycle progression, there is no further 
proliferation
47
. This functional inhibition of pRb by HPV E7 leads to increased 
expression of p16INK4a followed by its accumulation within the cells.  
1. p16INK4a is thus a surrogate marker of HPV E7-mediated pRb 
catabolism, providing evidence of transformation of the cervical 
mucosa
48,49
. The reason for using p16INK4a in classifying  
HPV-related lesions include: 
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2. Since there must be a continuous expression of E7 for the maintenance 
of the  malignant phenotype, the expression of p16INK4a has a direct 
correlation with the malignant potential of HPV oncogenic action 
3. Since p16 positivity is independent of the specific HPV type, 
genotyping is not necessary 
4. The expression of p16INK4a is a specific indication of HPV-E7 
overexpression or other events that lead to silencing of Rb
51
. 
             High grade intra epithelial neoplasia i.e. CIN-II ,CIN-III and squamous 
cell carcinoma of the cervix show diffuse staining of p16 .But in benign lesions of 
the cervix and low grade CIN-I which seem to be associated with low risk HPV, 
the expression is found to be very minimal or absent. The other conditions where 
focal and occasionally diffuse expression can be observed include benign 
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endocervical intercalated columnar cells, tuboendometrial metaplasia, and cervical 
endometriosis
52
. 
           The expression of p16INK4a in these cells, however, denotes no 
premalignant potential. There can be focal staining seen in the lower 1/3rd of CIN1 
lesions and in the upper third can show positivity in cases of squamous metaplasia. 
Only a diffuse staining of p16INK4a in the lower third of the epithelium, is 
considered specific for CIN1 lesions. Diffuse expression of p16  in glandular 
epithelial cells usually implies endocervical glandular neoplasia, Adeno carcinoma 
Insitu, or invasive adenocarcinoma.   
Many studies however take into consideration a dual staining that combines 
p16INK4a and Mib-1 and a positive scoring is done on the basis of individual cells 
which does not take cell morphology as a criteria.
53,54
 
OTHER PROGNOSTIC BIO MARKERS: 
LRIG: 
            LRIG, leucine-rich repeats, and immuno- globulin-like domains 1 (LRIG1) 
is a transmembrane protein, whose expression is considered  a good prognosis 
particularly in early stages of cervical cancer.
58
 It acts by inhibiting growth factor 
signaling by increasing  ubiquitylation followed by degradation of epidermal 
growth factor receptor (EGFR) .It can also act by inhibiting the cellular oncogenes 
Met and Ret.      
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COX-2 :  
           Several studies on High cyclooxygenase 2 (COX-2) reveal that its 
expression has a poor prognosis
55
. It is an essential enzyme in the conversion of 
arachidonic acid to prostaglandins and when it is expressed in large amounts it 
amplifies the metastatic potential and angiogenesis, and at the same time decreases 
host defense and apoptosis. 
EGFR2/HER2:               
The rapid progress of the tumor and resistance to therapy in malignancy of 
the cervix can be assessed by studying the expression of EGFR and human EGFR2 
(HER2) .Its expression is associated with poor prognosis
56
.   
D2-40 :              
D2-40 is a marker for endothelium that lines the lymphatic vessels. By 
evaluating the number of vessels that show positivity peritumoral lymphatic vessel 
density can be studied. It has a significant correlation with advanced tumor stage, 
lymph node metastases, and poor survival particularly in squamous cell 
carcinomas.
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VEGF:             
Overexpression of VEGF has been associated with tumor progression and 
poor prognosis in several tumors, including cervical cancer. Intratumoral protein 
levels of VEGF are increased in cervical cancer compared to normal cervical tissue 
and higher VEGF levels correlate with higher stage and increased risk of lymph 
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nodes metastasis . It has also been demonstrated that higher VEGF expression and 
increased tumor vascularisation are independent predictors of shorter disease-free 
interval and overall poor survival . 
P53 and RAS:                      
P53 and RAS mutations are not commonly expressed in cervical 
malignancies and in recent studies they do not seem to be associated with tumor 
stage, tumor grade, or survival. However ampliﬁcation and overexpression of 
cellular c-myc zncogene has been proved to be associated with HPV16. 
Overexpression of c-myc has also been associated with worse prognosis in some 
studies . 
CYCLIN E: 
Normal epithelium does not express Cyclin E, a nuclear protein that gets 
up-regulated by HPV 16 E7 directly linked to viral replication. It can be used to 
differentiate between low and high grade lesions when expressed in the nuclei. 
CD 4 positive lymphocytes : 
Infiltration of CD4 positive lymphocytes of tumor cells indicates better 
survival. Its expression is associated with good prognosis.   
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MATERIALS AND METHODS 
STUDY LOCATION:  
The study was undertaken in the Department of Pathology, Tirunelveli, 
Medical College.                  
STUDY PERIOD:  
            The study was conducted  from the years 2013 to 2015.  
SAMPLES:  
            A total of 50 cases including cervical intra epithelial neoplasia and 
carcinoma cervix. 
INCLUSION CRITERIA:  
1. Cervical biopsies diagnosed cervical intra epithelial neoplasia (I, II, III) 
and carcinoma cervix.  
2. Hysterectomy specimens diagnosed cervical intra epithelial neoplasia  
(I, II, III) and carcinoma cervix.  
EXCLUSION CRITERIA:  
1. Cervical biopsies reported as inflammatory conditions 
2. Cervical biopsies diagnosed mesenchymal lesion.  
3. Hysterectomy specimens for causes other than carcinoma cervix.  
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METHODOLOGY:  
DATA COLLECTION:  
The data including patients age, clinical staging, and other clinical data 
were obtained from the pathology records.  
PROCESSING OF SPECIMEN:          
Cervical biopsy specimens and hysterectomy specimens received were 
fixed in 10% formalin and processed routinely. Biopsy specimens were presented 
in to and in hysterectomy specimen, cervix was carefully sectioned to include 
endocervix and ectocervix.   
STAINING TECHNIQUE:  
Sections of 4-5µ thickness were cut and stained with Haematoxylin & 
Eosin. The slides were studied under light microscopy and the data recorded.  
IMMUNOHISTOCHEMICAL EVALUATION:                        
Immunohistochemistry was performed on 3-4m-thick sections taken on  
poly-L-lysine-coated slides. Antigen retrieval was performed by heating the 
sections in Tris-EDTA buffer at pH 6.0 using pressure cooker. Mouse Monoclonal 
antibody was used to bind with the primary antigen and is detected by adding 
secondary antibody conjugated with horse radish peroxidase – polymer and 
diaminobenzidine substrate. In this study, Ki-67 and p16 antigens of  Pathnsitu 
laboratory products is used.  
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PROCESSING FOR IMMUNOHISTOCHEMISTRY : 
 3µm thickness sections were cut using fresh blade in microtome from 
the chosen paraffin blocks.  
 The floated sections were taken in adhesive slides coated with poly-L-
lysine. 
 The slides were incubated overnight at 60 c.  
 The slides were subjected to 2 changes of xylene , 5  minutes each for 
deparaffinization.  
 They were then transferred to absolute alcohol for 5 minutes followed 
by  80% and 70% alcohol for 5 minutes to rehydrate the tissue sections.  
 Tissue sections were then washed in distilled water.  
 Antigen  retrieval was done using pressure cooker in Tris-EDTA buffer.          
 The sections were then cooled to room temperature and the slides  
washed with distilled water  
 Endogenous peroxidase activity was removed by incubating the tissue 
sections with enough drops of 3% peroxide block in a humid chamber 
for 5minutes.The sections were then washed in TRIS  wash buffer.  
 Primary antibody was then added to cover the tissue sections and 
incubated for 30 minutes.  
 The tissue sections were then washed in TRIS wash buffer followed by 
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 amplifier for 15 minutes to enhance the activity of  primary antibody 
which were then washed in TRIS  wash buffer. 
 Secondary antibody was then added and incubated for 20 minutes  
followed by washing with TRIS wash buffer.  
 DAB chromogen (1ml DAB buffer +1 drop DAB chromogen) was then 
added and incubated for 4 minutes and then washed with 2 changes of 
distilled water.  
 Counterstaining was done with haematoxylin for 30 seconds and washed 
in running tap water.  
This was followed by dehydration, clearing and mounting. 
SCORING OF Mib-1: 
Grading of Ki-67 expression: 
For Ki-67, immunopositivity was considered when there was strong nuclear 
staining. Because basal staining is a normal finding, the slides were first assessed 
for basal staining (lower one-third versus suprabasal). Staining in the upper two-
third of the epithelium was considered positive. 
The sections stained for Ki-67 proliferation (revealed as nuclear staining) 
were evaluated using scores from 1 to 3
59
 : 
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Table 2 : Grading of Ki-67 expression 
RATE OF 
POSITIVITY 
DEGREE OF 
PROLIFERATION 
GRADING 
>50% High Proliferation +++(3) 
30-50% Moderate Proliferation ++(2) 
10-30% Low Proliferation +(1) 
            
 
Calculation of MIB-1 Labelling Index
60
  
MIB-1 labelling index (LI) was calculated by the number of positive cells 
per 100 cervical epithelial cells in different areas under X400 magnification and 
the mean was calculated. Positive nuclei were expressed as the percentage of total 
nuclei counted.  
MIB-1 labelling  index was calculated as follows: 
No of cells showing positive staining  x 100 
Total No of cells 
P16 scoring: 
For p16, immunopositivity was considered when there was diffuse, strong, 
nuclear and/or cytoplasmic staining. Heterogeneous or focal moderate nuclear 
staining was also considered positive. Weak cytoplasmic staining was considered 
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negative. Grading was then performed for each case by the number of positive 
cells in different epithelial clusters as follows
61
: 
Table 3 : Scoring of p16 expression 
             GRADE             POSITIVITY 
                   0                      -- 
                   1                   1-10% 
                   2                  10-50% 
                   3                   >50% 
 
  
Evaluation of mitotic figures: 
In each case, the entire evaluable cervical epithelium was surveyed in a 
consistent manner by moving the microscopic field from the superficial to deep 
layers. Therefore, the total surface area of cervical epithelium evaluated was 
dependent on the number of sections initially obtained. Approximately 1000 cells 
were assessed under high power magnification for each specimen and the mitotic 
count is calculated as a percent for 100 cells. 
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OBSERVATION AND RESULTS 
 
Table 4 : Distribution of cases 
Diagnosis No. of cases 
CIN-I 14 
CIN-II 8 
CIN-III 6 
Carcinoma 22 
 
 
 
 
Chart:1 Distribution of study cases 
 
 
 
 
No. of cases 
CIN-I
CIN-II
CIN-III
Carcinoma
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Table 5 : Distribution of cases in carcinoma cervix 
Histological type No.of cases 
Large cell non keratinising squamous cell carcinoma 13 
Large cell keratinising squamous cell carcinoma 8 
Adenocarcinoma 1 
 
 
Table 6 : Comparison of mean of mitotic count 
 Mean mitotic count 
CIN-I 0.85 
CIN-II 1.3 
CIN-III 1.98 
LCNK 2.6 
LCK 2.5 
Adeno 0.9 
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Chart : 2 Comparison of mean of mitotic count 
 
 From the above table and the chart we infer that as the degree of dysplasia 
increases, the mean mitotic count also increases. Hence the mitotic count can be 
used to study the proliferative potential of the lesion. However the mitotic count in 
adenocarcinoma is less when compared to that in squamous cell carcinoma which 
may be due to its low proliferative potential. 
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Table 7 : Correlation between Ki-67 and p16 expression in study cases 
P16 
 
Ki-67 
 
Positive Negative 
Positive 28 11 
Negative 3 8 
           p value=0.013 (Fisher‟s exact test) 
          
 The above table shows a definite association between the expression of  
Ki-67 and p16 in cervical lesions (both benign and malignant) since 28 cases out 
of the 50 cases showed positivity for both the markers. Only 8 turned out to be 
negative for both.  P value is <0.05 and hence it is also statistically significant. 
 
Table 8 : Comparison of Ki-67 and p16 positivity in study cases 
  
Ki-67 
 
P16  
 
Total Positive % Positive % 
CIN-I 14 9 64.2 3 21.42 
CIN-II 8 5 62 5 62 
CIN-III 6 6 100 5 83 
LCK 8 8 100 8 100 
LCNK 13 12 92.3 9 69.2 
Adeno 1 0 0 0 0 
  P value=.0917(Pearson Chi-square test) 
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Chart : 3 Comparison of Ki-67 and p16 positive cases 
 The above table and the graph show that there is a expression of both Ki-67 
and p16 together in both CIN and carcinoma cervix. Further as the severity of the 
dysplasia increases, the positivity rate also increases. 
 P16 showed only 21% positivity in CIN-I lesions whereas in high grade 
dysplasias the positivity was above 60%. This  may be due to the association of 
HPV with high grade dysplastic lesions and malignancies of the cervix. However 
large cell non keratinising carcinomas showed only 70% positivity which 
emphasises the need to study if HPV is associated in these malignancies. 
 Ki-67 showed around 60% positivity even in CIN-I lesions though the 
grade was low. This rate keeps increasing then onwards.  
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Table 9 : Comparison of Ki-67 and p16 grading in CIN-I 
S.No Ki-67 P16 
1 2+ 0 
2 2+ 0 
3 2+ 1+ 
4 0 0 
5 3+ 0 
6 1+ 2+ 
7 2+ 0 
8 1+ 0 
9 2+ 0 
10 0 1+ 
11 0 0 
12 0 0 
13 1+ 0 
14 0 0 
 
 The above table shows variable expression of Ki-67 in CIN-I. Of the 13 
cases,4 turned out negative whereas 1 showed 3+ positivity. The remaining 
showed 1+ and 2+positivity. This means that not all CIN-I cases have low 
malignant potential and a careful follow up is necessary. However the overall 
expression of p16 in CIN-I turned out to be low. Only 3 of them were positive. 
This may be due to the low association of HPV with these lesions.  
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Table 10 : Comparison of Ki-67 and p16 grading in CIN-II 
S.No Mib-labelling index: P16 Ki-67 P16 
1 3+ 2+ 
2 0 0 
3 0 1+ 
4 0 0 
5 1+ 0 
6 1+ 2+ 
7 1+ 3+ 
8 1+ 1+ 
 
 
 Nearly 50% of cases showed expression of Ki-67 and p16. 50% of cases 
showed 1+ Ki-67 positivity.3 turned out negative and one showed 3+ positivity. 
There was higher degree of expression in p16 compared to Ki-67 with only 3 of 
them being negative. 
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Table 11 : Comparison of ki-67 and p16 expression in CIN-III 
S.No Ki-67  P16 
1 1+ 1+ 
2 3+ 1+ 
3 2+ 1+ 
4 3+ 2+ 
5 3+ 0 
6 1+ 2+ 
 
 
         Nearly all cases showed positive expression of both ki-67 and p16.In ki-67v 
positive cases, >50% showed 3+ and the remaining showed 1+ / 2+ positivity. This 
means not all CIN-III lesions have a high proliferation index where conservative 
treatment may be thought of P16 expression was negative in only one case that 
showed 3+Ki-67 positivity. The other cases showed 1+/2+ positivity which may be 
due to the low viral  load in these cases. Further proliferation need not always be 
associated with HPV. 
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Table 12 : Comparison of ki-67 and p16 expression in large cell non 
keratinising carcinoma 
S.No Ki-67 P16 
1 3+ 0 
2 3+ 1+ 
3 3+ 0 
4 3+ 3+ 
5 0 0 
6 3+ 3+ 
7 2+ 2+ 
8 3+ 3+ 
9 3+ 2+ 
10 2+ 2+ 
11 3+ 3+ 
12 3+ 0 
13 3+ 1+ 
 
 The positivity of ki-67 and p-16 expression is very high in large cell non 
keratinising carcinoma. Ki-67 shows 2+ and above positivity in all cases except for 
one which showed no expression.p16 also showed 2+ and above positivity in more 
than 50% of cases.4 of them showed no expression. One case was negative for 
both the markers which may imply its low proliferative potential. 
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Table 13 : Comparison of ki-67 and p16 expression in  
large cell keratinising carcinoma 
S.No Ki-67 P16 
1 3+ 2+ 
2 3+ 3+ 
3 2+ 2+ 
4 3+ 2+ 
5 3+ 1+ 
6 2+ 3+ 
7 2+ 2+ 
8 3+ 3+ 
    
            The above table shows that there is a high degree of both ki-67 and p16  
expression in large cell keratinising carcinoma.i.e.2+/3+positivity. 
 
 
Table 14 : Ki-67 and p16 expression in adeno carcinoma 
S.No Ki-67 P16 
1 0 0 
 
 There is no expression of either ki-67and p16 in adeno carcinoma. However 
since  only one case has been studied, its significance cannot be proved.  
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Table 15 : Comparison of expression of  Ki-67 in the study cases  
Ki-67 0 1 2 3 
CIN-I 5 3 5 1 
CIN-II 3 4 0 1 
CIN-III 0 2 1 3 
LCK 0 0 4 4 
LCNK 1 0 2 10 
Adeno 1 0 0 0 
 
 The table shows that the CIN-I lesions predominantly show either no or 
grade 1 expression. An exception is one of them showing grade III expression. The 
carcinomas show either grade 2 or 3 expression which may point towards their 
aggressiveness .Adenocarcinoma showed no expression. 
Table 16 : Comparison of expression of p16 in the study cases 
P16 0 1 2 3 
CIN-I 10 2 2 0 
CIN-II 3 2 2 1 
CIN-III 1 2 2 1 
LCK 0 1 3 4 
LCNK 4 2 3 4 
Adeno 1 0 0 0 
      
 P16 did not show expression in many of the CIN-I cases whereas CIN-II 
and III showed some positivity in all cases. The squamous cell carcinomas showed 
higher grades of positivity. Thus as the severity increases, the degree of positivity 
also increases. 
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Table 17 : Comparison of mean if Mib-1 labelling index 
Diagnosis Mib-1 LI 
CIN-I 13 
CIN-II 15.75 
CIN-III 36.8 
LCK 44.8 
LCNK 45.4 
Adeno 0 
 
 
Chart : 4 Comparison of mean of Mib-1 labelling index 
 
          The above graph shows as the lesion progresses through increasing grades of  
dysplasia, the Mib-1 labelling index also increases which implies that the 
malignant potential increases. 
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Table 18 : Comparison of mean of mitotic count with that of Mib-1LI 
Diagnosis 
Mean Mib-1 
LI 
Mean mitotic 
count 
CIN-I 13 0.85 
CIN-II 15.75 1.3 
CIN-III 36.8 1.98 
LCK 44.8 2.6 
LCNK 45.4 2.5 
Adeno 0 0.9 
P value (Pearson chi square test) = 0.014 
 
              Chart : 5 Comparison of mean mitotic count with mean Mib-1 LI 
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 From the above table, we infer that the mean of mitotic count and Mib-1 LI 
increase with increasing dysplasia. This association also has statistical significance 
(p value<0.05). 
Table 19: Comparison of mitotic count with Ki-67 and p16 expression 
  
Pearson 
Correlation 
P Value 
Mitotic count 
MIB 0.587 <0.0001 
P16 0.372 0.008 
 
          P value being significant shows an association between the mitotic count 
and the expression of Ki-67 and p16 individually. 
                                                                    
 
 
 
 
                                                                         
 
 
                                            
    
 
 
 
 
 
  
 
 
       
  
Fig. 6. High power photomicrograph of a case of CIN-I  showing 3+nuclear  
positivity of Ki-67 
 
 
 
 
 
 
  
 
 
         
 
Fig.7. Photomicrograph showing 3+nuclear positivity of Ki-67 in a case of 
large cell non keratinising carcinoma 
 
 
 
 
 
 
  
 
 
 
 
Fig. 8. Low power view of grade 3+ p16 positivity in large cell non 
keratinising carcinoma 
 
 
 
 
 
  
 
 
 
 
Fig. 9. Photomicrograph showing 3+nuclear and cytoplasmic positivity of p16 
in a large cell non keratinising carcinoma 
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DISCUSSION 
         Carcinoma cervix remains the leading cause of deaths due to cancer in India. 
Much efforts have been taken to bring down the mortality through screening 
programmes at various levels of the health sectors. However as already mentioned, 
this is subjected to inter observer variation which can be overcome by the use of 
bio markers. 
            The screening programmes are based on the fact that neoplasia of the 
cervix is preceeded by a long period of slow progress through intra epithelial 
stages. Further the association of this cancer with an infectious agent, HPV has 
also been widely studied based on which they are categorised into low and high 
risk types. This helps in making use of the various bio markers to study the 
proliferative potential and the outcome of these lesions.  
Ki-67 as well known is a proliferative marker that is expressed in all stages 
of the cell cycle except G0 phase.
62
 It is used in various malignancies to study the 
aggressiveness so that appropriate treatment can be implemented. It is highly 
accurate in demonstrating the cervical lesions with high potential of turning into  
malignancy. Thus this marker is widely used to prognosticate dysplastic lesions of 
the cervix. 
           P16 is a tumor suppressor protein that is encoded by the CDKN2A
 
gene
. 
Its 
major role in cell cycle is down regulation of cell cycle by inhibiting the 
progression of cell cycle from G1 to S phase
63
. It has its effect expressed through 
the HPV genome. It has wide application in malignancies like squamous cell 
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carcinoma and melanoma. Since the majority of cervical malignancies reported 
come under the squamous variant, its use in these malignancies is definite. 
With the studies available, the expression of Ki-67 and p16 were studied in 
both dysplastic and malignat lesions of the cervix to understand the prognosis of 
the same which cannot be done through histopathological examination though 
wide arrays of potential biomarkers have been evaluated for the diagnostic 
usefulness of cervical cancer and its precursors. These studies were mainly done to 
minimise the surgical intervention and to bring down the costs of repeated 
screening programmes.            
          In a study by C. H.Chi, MD et al., (1977), the distribution of mitotic figures 
which were studied revealed that the mitotic figures which were normally confined 
to the basal layer showed an increase in both frequency and distribution as the 
grade of dysplasia increases
64,65
. This study also showed an increase in mean 
mitotic count with increasing grades of dysplasia.
 
In the study by Srivastava S.et al. (2010),
66
 the expression of MIB-I 
increased from normal cervical epithelia to varying severity of CINs to carcinoma. 
It was statistically significant when comparison was between controls and cases 
and the same was insignificant within the groups. MIB-I positivity was seen in 14 
of 15 cases of CIN I, 15 of 15 cases of CIN II, 3 of 3 cases of CIN III and 15 of 15 
cases of carcinoma cervix. 
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In this study also, 9 of 14 CIN-I, 5 of 8 CIN-II, 6 of 6 CIN-III cases,  
20 of 21 carcinoma cases showed Ki-67 expression. The % expression also 
showed a constant increase from 64% in CIN-1 to 100% in malignant cases.  
However, one case of CIN-I showed grade III positivity which may indicate the 
lesion would progress vigorously.  
In the same study, p16 INK4A overexpression was seen in all CIN I lesions 
(15/15), all CIN II lesions (15/15), all CIN III lesions (3/3) and all cases of 
carcinoma cervix (15/15) of tissue biopsies.        
In a study by Klaes et al. (2001),
67
 positive expression of p16 was found in 
all CIN I lesions (n = 47), all CIN II lesions (n = 32), all CIN III lesions (n = 60) 
and 56 of 58 invasive Squamous cell carcinoma (SCC). However this expression 
was found to  be minimal in inflammatory and low grade dysplasias. 
In the present study, p16 expression was very much less (4/14, i.e.21%) in 
CIN-1 compared to the above study .The expression in CIN II and CIN-III was 
also less (62% and 83%). However the expression in malignant lesions was similar 
to the above study. 
In the same study by Srivastava S.et al. (2010), correlation between Ki-67 
and p16 expression was, an increasing p16 expression with consistently increasing 
MIB-1 LI in the groups of increasing severity. In this study also, the correlation 
between the two markers was seen and it was also statistically significant. 
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          Gupta et al. Gynecol Obstet 2013,
68
 study which  comprised of 20 cases of 
dysplasia and 30 cases of carcinomas revealed that the mean value of LI (Labelling 
Index) was found to increase as the nature of the lesion changed from dysplasia 
(16.94) to carcinoma (50.754) with the difference being found to be extremely 
statistically significant ( p value <0.0001). 
MIB-1 LI also showed an increase with increase in dysplasia from  
CIN-I (13)  to carcinoma (45.1) in this study. Further, the correlation between the 
mean of mitotic count and that of the Mib-1 was also statistically significant. 
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CONCLUSION 
         
 Ki-67 and p16 expression were seen in CIN-I, II, III and squamous cell 
carcinomas of the cervix with statistically significant correlation of 
expression between them. 
 The mean mitotic count increases with increasing dysplasia which is an 
indirect measure of proliferative potential. It also showed statistically 
significant correlation with mean MIB-1 LI.  
 Though all CIN-I cases showed a low Ki-67 positivity, one showed 3+ 
positivity. This implies that not all CIN-I cases have low malignant 
potential and a cautious follow up of such cases is mandatory. 
 The scoring of expression of Ki-67 increases with increasing dysplasia of 
the lesion. However even high grade dyplasias showed 0/1+ positivity 
which indicates their low proliferative potential and hence the tumor 
progression may be slow in such cases which requires a long term follow 
up. 
 p16 had a better expression in high grade intra epithelial lesions(60-80%) 
and malignancies (100%) of the cervix compared to low grade dysplasias 
(21%) which  may be due to  the integration of HPV with high grade 
lesions. Further LCNK variant showed a lesser positivity (70%) compared 
to LCK carcinomas (100%). This may be due to the lesser prevalence of 
HPV in this histological subtype.  
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 Adeno carcinoma did not show Ki-67/p16 positivity which had shown 
positive results in recent studies. But since only one case has been studied, 
this cannot be emphasised.  
 To conclude, Ki-67 and p16 expression in pre malignant and malignant 
lesions of the Cervix can be used in conjunction with the histo 
morphological features to study their proliferative potential and thereby 
their progression which would have a major impact on the treatment. 
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MASTER CHART FOR STUDY CASES 
S. 
No 
Age I.P.No Path. No Diagnosis 
Mitotic 
count 
(%) 
Ki-67 
expression 
P16 
expression 
grading 
Mib-1 
LI 
1 62 30805/15 1180/15 LCNK 2.8 3+ 0+ 57 
2 43 25152/15 1245/15 CIN-I 0.9 2+ 0+ 35 
3 38 34626/15 1373/15 CIN-I 1.1 2+ 0+ 25 
4 45 16336/15 668/15 CIN-II 1.3 3+ 2+ 38 
5 43 257482/15 207/15 CIN-I 0.7 2+ 1+ 22 
6 50 6478/15 320/15 LCK 2.3 3+ 2+ 42 
7 41 239242/15 2973/14 CIN-I 0.8 0 0+ 0 
8 40 59902//14 3053/14 CIN-II 1.1 0+ 0+ 0 
9 45 61054/14 3008/14 LCNK 2.5 3+ 1+ 45 
10 45 14696/15 686/15 CIN-I 0.8 3+ 0+ 34 
11 48 43271/14 3025/14 LCNK 3 3+ 0+ 59 
12 70 26889/15 1053/15 LCNK 2.6 3+ 3+ 49 
13 42 23225/15 1045/15 CIN-I 0.8 1+ 2+ 13 
14 52 64062/14 3104/14 Adeno 0.9 0+ 0+ 0 
15 60 59671/14 3005/14 LCK 1.7 3+ 3+ 62 
16 70 22754/15 973/15 LCNK 2.3 0+ 0+ 0 
17 55 17909/15 914/15 LCNK 2.9 3+ 3+ 52 
18 75 17090/15 918/15 LCNK 1.8 2+ 2+ 39 
19 75 23178/15 958/15 LCNK 2.3 3+ 3+ 48 
20 70 28903/15 1011/15 LCK 3.2 2+ 2+ 35 
21 55 62538/14 3080/14 LCK 2.7 3+ 2+ 47 
22 30 13020/14 701/14 CIN-I 1.1 2+ 0+ 21 
23 70 25270/14 1305/14 CIN-I 0.9 1+ 0+ 10 
24 40 8328/15 336/15 CIN-III 2.5 1+ 1+ 23 
25 53 38861/14 1930/14 LCK 2.9 3+ 1+ 66 
26 51 4683/15 248/15 LCNK 3.1 3+ 2+ 59 
27 60 1227/15 142/15 CIN-III 2.2 3+ 1+ 47 
 
 
S. 
No 
Age I.P.No Path. No Diagnosis 
Mitotic 
count 
(%) 
Ki-67 
expression 
P16 
expression 
grading 
Mib-1 
LI 
28 59 6526/15 324/15 LCK 2.8 2+ 3+ 27 
29 36 72932/15 35/15 CIN-I 1.3 2+ 0+ 22 
30 65 888/15 147/15 LCNK 3.3 2+ 2+ 44 
31 65 6815/15 284/15 CIN-III 1.2 2+ 1+ 48 
32 30 220514/14 2254/14 CIN-II 0.9 0+ 1+ 0 
33 60 8833/15 378/15 CIN-III 2.2 3+ 2+ 51 
34 31 228180/14 2608/14 CIN-II 1.5 0+ 0+ 0 
35 31 68664/13 2793/13 CIN-II 1.3 1+ 0+ 27 
36 38 5443/15 87/15 CIN-III 2.7 3+ 0+ 35 
37 55 34823/14 2081/14 CIN-I 1 0+ 1+ 0 
38 35 37347/14 1880/14 CIN-I 0.7 0+ 0+ 0 
39 49 19980/15 802/15 LCNK 2.6 3+ 3+ 43 
40 50 45030/14 2249/14 CIN-I 0.6 0+ 0+ 0 
41 51 40576/10 2032/14 CIN-I 0.5 1+ 0+ 0 
42 72 60596/14 3071/14 LCNK 2 3+ 0+ 57 
43 30 9253/15 385/15 LCK 3.1 2+ 2+ 31 
44 72 62509/14 3099/14 CIN-II 1.2 1+ 2+ 21 
45 70 62972/14 3063/14 LCK 1.9 3+ 3+ 49 
46 35 9235/15 381/15 CIN-II 0.9 1+ 3+ 27 
47 43 4458/15 345/15 CIN-III 1.1 1+ 2+ 43 
48 36 179052/15 366/15 CIN-I 1 0+ 0+ 0 
49 47 4716/15 243/15 LCNK 3.2 3+ 1+ 39 
50 44 45851/14 2385/14 CIN-II 2.1 1+ 1+ 13 
 
 
 
  
 
 
ANNEXURE - I 
WHO CLASSIFICATION OF CERVICAL TUMORS 
EPITHELIAL TUMORS:  
Squamous tumors and precursors  
Squamous cell carcinoma, not otherwise specified         
 Keratinising  
 Non keratinising  
 Basaloid   
 Verrucous   
 Warty 
 Papillary  
 Lymphoepithelioma  
 Squamotransistional   
Early invasive ( microinvasive) squamous cell carcinoma 
Squamous intraepithelial neoplasia  
 Cervical intraepithelial neoplasia(CIN3)  
 Squamous cell carcinoma in situ  
Benign squamous cell lesions  
 Condyloma accuminatum  
 Fibroepithelial polyp  
  
 
 
Glandular tumors and precursors  
Adenocarcinoma   
 Mucinous adenocarcinoma  
 Endocervical  
 Intestinal  
 Signet-ring cell  
 Minimal deviation  
 Villoglandular  
 Endometrioid adenocarcinoma  
 Clear cell adenocarcinoma  
 Serous adenocarcinoma  
 Mesonephric adenocarcinoma  
Early invasive adenocarcinoma   
Adenocarcinoma in situ                 
Glandular dysplasia  
Benign glandular lesions  
 Mullerian papilloma  
 Endocervical polyp  
Other epithelial tumors  
 Adenosquamous carcinoma  
 Glassy cell carcinoma variant  
 Adenoid cystic carcinoma   
 Adenoid  basal carcinoma  
 Neuroendocrine tumors  
 
 
 Carcinoid  
 Atypical carcinoid  
 Small cell carcinoma  
 Large cell neuroendocrine carcinoma  
 Undifferentiated carcinoma       
MESENCHYMAL TUMORS AND TUMOR LIKE CONDITIONS  
 Leiomyosarcoma  
 Endometrioid stromal sarcoma, low grade  
 Undifferentiated endocervical sarcoma  
 Sarcoma botryoides  
 Alveolar soft part sarcoma  
 Angiosarcoma  
 Malignant peripheral nerve sheath tumor  
 Leiomyoma  
 Genital rhabdomyoma  
 Postperative spindle cell nodule   
MIXED EPITHELIAL AND MESENHYMAL LESIONS  
 Carcinomasarcoma  
 Adenosarcoma  
 Wilms tumor  
 Adenofibroma  
 Adenomyoma  
 Melanocytic tumors  
 
 
MISCELLANEOUS TUMORS  
 Tumors of germ cell type  
 Yolk sac tumor  
 Dermoid cyst  
 Mature cystic teratoma  
 Lymphoid hematopoeitic tumors  
 Secondary tumors  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                               
  
 
 
ANNEXURE - II 
Staging is done by FIGO staging (94)   
Stage I   
 
Cervical carcinoma confined to uterus (extension to the corpus 
should be disregarded) 
Stage IA 
 
Invasive carcinoma diagnosed only by microscopy; all  
macroscopically visible lesions, even with superficial invasion, 
are stage IB 
Stage IA1  
 
Stromal invasion no greater than 3.0 mm in depth and 7.0 mm or  
less in horizontal spread  
Stage IA2 
 
Stromal invasion more than 3.0 mm and not more than 5.0 mm 
with a horizontal spread of 7.0 mm or less  
Stage IB Clinically visible lesion confined to the cervix or microscopic 
lesion greater than IA2  
Stage IB1 Clinically visible lesion 4.0 cm or less in greatest dimension 
Stage IB2 Clinically visible lesion more than 4.0 cm in greatest dimension 
Stage II Tumor invades beyond the uterus but not to pelvic wall or to 
lower third of the vagina  
Stage IIA  Without parametrial invasion  
Stage IIA1 Clinically visible lesion _4.0 cm in greatestdimension 
Stage IIA2 Clinically visible lesion >4 cm in greatest dimension 
Stage IIB  With parametrial invasion  
Stage III  
 
Tumor extends to the pelvic wall and/or involves lower third of 
vagina and/or causes hydronephrosis or nonfunctioning kidney  
Stage IIIA  
 
Tumor involves lower third of vagina with no extension to 
pelvic wall  
Stage IIIB  
 
Tumor extends to pelvic wall and/or causes hydronephrosis or  
nonfunctioning kidney  
Stage IV  
 
The carcinoma has extended beyond the true pelvis or has 
involved (biopsy proven) the mucosa of the bladder or rectum.  
Stage IVA  Spread of the growth to adjacent organs 
Stage IVB  Spread to distant organs    
  
